These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 'Off-label' drug use: an FDA regulatory term, not a negative implication of its medical use. Meadows WA; Hollowell BD Int J Impot Res; 2008; 20(2):135-44. PubMed ID: 18004389 [TBL] [Abstract][Full Text] [Related]
5. [Off-label prescribing]. Blondon K; Desmeules J; Vogt-Ferrier N; Besson M; Kondo-Oestreicher M; Dayer P Rev Med Suisse; 2008 Jul; 4(165):1661-5. PubMed ID: 18767292 [TBL] [Abstract][Full Text] [Related]
6. Satisfaction with pharmacotherapy for approved and off-label indications--a Delphi study. Kos M; Wertheimer AI; Mrhar A Ann Pharmacother; 2005 Apr; 39(4):649-54. PubMed ID: 15755789 [TBL] [Abstract][Full Text] [Related]
7. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women's Hospital. Herring C; McManus A; Weeks A Int J Pharm Pract; 2010 Aug; 18(4):226-9. PubMed ID: 20636674 [TBL] [Abstract][Full Text] [Related]
9. [Off-label prescriptions in dermatology]. Joly P Ann Dermatol Venereol; 2003 May; 130(5):505-6. PubMed ID: 12843824 [No Abstract] [Full Text] [Related]
10. Drug, patient, and physician characteristics associated with off-label prescribing in primary care. Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695 [TBL] [Abstract][Full Text] [Related]
11. Positive outcomes through the appropriate use of off-label prescribing. Bright JL Arch Intern Med; 2006 Dec 11-25; 166(22):2554-5; author reply 2555. PubMed ID: 17159026 [No Abstract] [Full Text] [Related]
12. A survey of off-label prescribing for inpatients with mild intellectual disability and mental illness. Haw C; Stubbs J J Intellect Disabil Res; 2005 Nov; 49(Pt 11):858-64. PubMed ID: 16207284 [TBL] [Abstract][Full Text] [Related]
13. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings. Sneed RC; May WL; Stencel C Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092 [TBL] [Abstract][Full Text] [Related]
14. Off-label use of drugs in pain medicine and palliative care: an algorithm for the assessment of its safe and legal prescription. Verhagen CC; Niezink AG; Engels YY; Hekster YY; Doornebal JJ; Vissers KC Pain Pract; 2008; 8(3):157-63. PubMed ID: 18373512 [TBL] [Abstract][Full Text] [Related]
15. Prescribing of sulfasalazine, azathioprine and methotrexate round pregnancy--a descriptive study. Vroom F; van Roon EN; van den Berg PB; Brouwers JR; de Jong-van den Berg LT Pharmacoepidemiol Drug Saf; 2008 Jan; 17(1):52-61. PubMed ID: 17948319 [TBL] [Abstract][Full Text] [Related]
16. U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey. Chen DT; Wynia MK; Moloney RM; Alexander GC Pharmacoepidemiol Drug Saf; 2009 Nov; 18(11):1094-100. PubMed ID: 19697444 [TBL] [Abstract][Full Text] [Related]
17. Uses of drugs not described in the package insert (off-label uses). Committee on Drugs. American Academy of Pediatrics Pediatrics; 2002 Jul; 110(1 Pt 1):181-3. PubMed ID: 12093968 [TBL] [Abstract][Full Text] [Related]